BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37700640)

  • 1. Knockdown of PRMT1 suppresses the malignant biological behavior of osteosarcoma cells and increases cisplatin sensitivity via c-Myc-mediated BCAT1 downregulation.
    Li Z; Meng D; Liu Y; Bi F; Tian K; Xu J; Sun J; Gu C; Li Y
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23537. PubMed ID: 37700640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geranylgeranylacetone promotes human osteosarcoma cell apoptosis by inducing the degradation of PRMT1 through the E3 ubiquitin ligase CHIP.
    Jiang L; Liao J; Liu J; Wei Q; Wang Y
    J Cell Mol Med; 2021 Aug; 25(16):7961-7972. PubMed ID: 34155784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism.
    Luo L; Sun W; Zhu W; Li S; Zhang W; Xu X; Fang D; Grahn THM; Jiang L; Zheng Y
    Cell Death Dis; 2021 Feb; 12(2):169. PubMed ID: 33568627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCAT1 overexpression regulates proliferation and c‑Myc/GLUT1 signaling in head and neck squamous cell carcinoma.
    Wang H; Wang F; Ouyang W; Jiang X; Wang Y
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma.
    Zhou W; Feng X; Ren C; Jiang X; Liu W; Huang W; Liu Z; Li Z; Zeng L; Wang L; Zhu B; Shi J; Liu J; Zhang C; Liu Y; Yao K
    Mol Cancer; 2013 Jun; 12():53. PubMed ID: 23758864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin.
    Zheng YH; Hu WJ; Chen BC; Grahn TH; Zhao YR; Bao HL; Zhu YF; Zhang QY
    Liver Int; 2016 Dec; 36(12):1836-1847. PubMed ID: 27246112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
    Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOTAIR Promotes Cisplatin Resistance of Osteosarcoma Cells by Regulating Cell Proliferation, Invasion, and Apoptosis via miR-106a-5p/STAT3 Axis.
    Guo J; Dou D; Zhang T; Wang B
    Cell Transplant; 2020; 29():963689720948447. PubMed ID: 32757663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
    Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
    Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
    Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIPE1 inhibits osteosarcoma tumorigenesis and progression by regulating PRMT1 mediated STAT3 arginine methylation.
    Yang M; Zhang Y; Liu G; Zhao Z; Li J; Yang L; Liu K; Hu W; Lou Y; Jiang J; Liu Q; Zhao P
    Cell Death Dis; 2022 Sep; 13(9):815. PubMed ID: 36151091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
    Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
    EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressing PRMT1 Inhibits Proliferation and Invasion in Pancreatic Cancer by Inverse Correlation of ZEB1.
    Lin Z; Chen Y; Lin Z; Chen C; Dong Y
    IUBMB Life; 2018 Oct; 70(10):1032-1039. PubMed ID: 30194893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.
    Zhou Y; Huang Z; Wu S; Zang X; Liu M; Shi J
    J Exp Clin Cancer Res; 2014 Jan; 33(1):12. PubMed ID: 24468065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
    Xie XK; Yang DS; Ye ZM; Tao HM
    Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma.
    Tsai HC; Huang CY; Su HL; Tang CH
    PLoS One; 2014; 9(3):e90159. PubMed ID: 24637722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA VPS18 Promotes Glioblastoma Progression by Regulating miR-1229-3p/BCAT1 Axis.
    Huang Q; Li W; Huang Y; Chen Q; Wei W
    Neurotox Res; 2022 Oct; 40(5):1138-1151. PubMed ID: 35776379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRMT1 accelerates cell proliferation, migration, and tumor growth by upregulating ZEB1/H4R3me2as in thyroid carcinoma.
    Feng G; Chen C; Luo Y
    Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37859611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flotillin-2 promotes cell proliferation via activating the c-Myc/BCAT1 axis by suppressing miR-33b-5p in nasopharyngeal carcinoma.
    Liu R; Liu J; Wu P; Yi H; Zhang B; Huang W
    Aging (Albany NY); 2021 Mar; 13(6):8078-8094. PubMed ID: 33744853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63.
    Liu HC; Zeng J; Zhang B; Liu XQ; Dai M
    J Cell Physiol; 2019 Jun; 234(6):9358-9369. PubMed ID: 30456894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.